Biology of Blood and Marrow Transplantation
Volume 14, Issue 9, Supplement , Pages 45-53 , September 2008

National Marrow Donor Program HLA Matching Guidelines for Unrelated Adult Donor Hematopoietic Cell Transplants

  • Robert A. Bray

      Affiliations

    • Department of Pathology, Emory University, Atlanta, Georgia
    • ,
  • Carolyn K. Hurley

      Affiliations

    • Department of Oncology, Georgetown University, Washington, DC
    • ,
  • Naynesh R. Kamani

      Affiliations

    • Division of Blood and Marrow Transplantation/Immunology, Children's National Medical Center, Washington, DC
    • ,
  • Ann Woolfrey

      Affiliations

    • Fred Hutchinson Cancer Research Center, Seattle, Washington
    • ,
  • Carlheinz Müller

      Affiliations

    • German National Bone Marrow Registry/ZKRD, Ulm, Germany
    • ,
  • Stephen Spellman

      Affiliations

    • National Marrow Donor Program, Minneapolis, Minnesota
    • Corresponding Author InformationCorrespondence and reprint requests: Stephen Spellman, National Marrow Donor Program, 3001 Broadway Street NE, Minneapolis, MN 55413.
    • ,
  • Michelle Setterholm

      Affiliations

    • National Marrow Donor Program, Minneapolis, Minnesota
    • ,
  • Dennis L. Confer

      Affiliations

    • National Marrow Donor Program, Minneapolis, Minnesota

Received 20 February 2008 ,Accepted 17 June 2008.

References 

  1. Hurley CK, Baxter-Lowe LA, Logan B, et al. National Marrow Donor Program HLA matching guidelines for unrelated marrow transplants. Biol Blood Marrow Transplant. 2003;9:610–615
  2. Cano P, Klitz W, Mack SJ, et al. Common and well-documented HLA alleles: report of the Ad-Hoc Committee of the American Society for Histocompatiblity and Immunogenetics. Hum Immunol. 2007;68:392–417
  3. Petersdorf EW. Immunogenetics of unrelated hematopoietic stem cell transplantation. Curr Opin Immunol. 2006;18:559–564
  4. Morishima Y, Sasazuki T, Inoki H, et al. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. Blood. 2002;99:4200–4206
  5. Petersdorf EW, Gooley TA, Anasetti C, et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood. 1998;92:3515–3520
  6. Petersdorf EW, Gooley T, Malkki M, et al. The biological significance of HLA-DP gene variation in haematopoietic cell transplantation. Br J Haematol. 2001;112:988–994
  7. Petersdorf EW, Hansen JA, Martin PJ, et al. Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation. N Engl J Med. 2001;345:1794–1800
  8. Petersdorf EW, Anasetti C, Martin PJ, et al. Limits of HLA mismatching in unrelated hematopoietic cell transplantation. Blood. 2004;104:2976–2980
  9. Flomenberg N, Baxter-Lowe LA, Confer D, et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood. 2004;104:1923–1930
  10. Lee SJ, Klein J, Haagenson M, et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood. 2007;110:4576–4583
  11. Shaw B, Gooley T, Malkki M, et al. The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation. Blood. 2007;110:4560–4566
  12. Eapen M, Logan BR, Confer DL, et al. Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival. Biol Blood Marrow Transplant. 2007;13:1461–1468
  13. Eapen M, Rubinstein P, Zhang MJ, et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet. 2007;369:1947–1954
  14. Kamani N, Spellman S, Hurley CK, et al. State of the art review: HLA matching and outcome of unrelated donor umbilical cord blood transplants. Biol Blood Marrow Transplant. 2008;14:1–6
  15. Kollman C, Howe CW, Anasetti C, et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood. 2001;98:2043–2051
  16. Petersdorf EW, Gooley T, Malkki M, et al. Clinical significance of donor-recipient HLA matching on survival after myeloablative hematopoietic cell transplantation from unrelated donors. Tissue Antigens. 2007;69(Suppl 1):25–30
  17. Wade JA, Hurley CK, Takemoto SK, et al. HLA mismatching within or outside of cross-reactive groups (CREGs) is associated with similar outcomes after unrelated hematopoietic stem cell transplantation. Blood. 2007;109:4064–4070
  18. Shaw BE, Barber LD, Madrigal JA, et al. Scoring for HLA matching? A clinical test of HistoCheck. Bone Marrow Transplant. 2004;34:367–368
  19. Morishima Y, Kawase T, Malkki M, et al. Effect of HLA-A2 allele disparity on clinical outcome in hematopoietic cell transplantation from unrelated donors. Tissue Antigens. 2007;69(Suppl 1):31–35
  20. Taylor PA, Ehrhardt MJ, Roforth MM, et al. Preformed antibody, not primed T-cells is the initial and major barrier to bone marrow engraftment in allosensitized patients. Blood. 2007;109:1307–1315
  21. Ottinger HD, Rebmann V, Pfeiffer KA, et al. Positive serum crossmatches predictor for graft failure in HLA mismatched allogeneic blood stem cell transplantation. Transplantation. 2002;73:1280–1285
  22. Bray RA, Rosen-Bronson S, Haagenson M, et al. The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure. Blood. 2007;110
  23. Giralt S, Logan B, Rizzo D, et al. Reduced-intensity conditioning for unrelated donor progenitor cell transplantation: long-term follow-up of the first 285 reported to the National Marrow Donor Program. Biol Blood Marrow Transplant. 2007;13:844–852
  24. Wagner JE, Thompson JS, Carter SL, et al. Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre, randomized phase II-III trial. Lancet. 2005;2:344:692-694
  25. Petersdorf EW, Malkki M, Gooley TA, et al. MHC haplotype matching for unrelated hematopoietic cell transplantation. PLoS Med. 2007;4:e8
  26. Ruggeri L, Capanni M, Urgani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 2002;295:2097–2100
  27. Farag SS, Bacigalupo A, Eapen M, et al. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the Center for International Blood and Marrow Transplant Research, the European Blood and Marrow Transplant Registry, and the Dutch Registry. Biol Blood Marrow Transplant. 2006;12:876–884
  28. Hsu KC, Gooley T, Malkki M, et al. KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy. Biol Blood Marrow Transplant. 2006;12:828–836
  29. Yu J, Heller G, Chewning J, Kim S, Yokoyama WM, Hsu KC. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands. J Immunol. 2007;179:5977–5989
  30. Cooley S, Xiao F, Pitt M, et al. A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature. Blood. 2007;110:578–586

 STATEMENT OF CONFLICT OF INTEREST: See Acknowledgements on page 52.

PII: S1083-8791(08)00274-7

doi: 10.1016/j.bbmt.2008.06.014

Biology of Blood and Marrow Transplantation
Volume 14, Issue 9, Supplement , Pages 45-53 , September 2008

Article Tools

* Image Usage & Resolution